X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1234) 1234
index medicus (775) 775
dermatology (656) 656
male (551) 551
female (541) 541
imiquimod 5-percent cream (420) 420
middle aged (351) 351
double-blind (341) 341
aged (329) 329
adult (312) 312
imiquimod (292) 292
5-percent (291) 291
treatment outcome (289) 289
5-percent cream (237) 237
administration, topical (231) 231
surgery (229) 229
care and treatment (221) 221
aminoquinolines - therapeutic use (216) 216
anesthesiology (185) 185
skin neoplasms - drug therapy (182) 182
animals (180) 180
efficacy (172) 172
aminoquinolines - administration & dosage (162) 162
photodynamic therapy (159) 159
pharmacology & pharmacy (152) 152
aged, 80 and over (151) 151
antineoplastic agents - therapeutic use (145) 145
administration, cutaneous (140) 140
skin neoplasms - pathology (140) 140
management (139) 139
basal-cell carcinoma (133) 133
cancer (133) 133
skin (129) 129
actinic keratosis (127) 127
therapy (124) 124
squamous-cell carcinoma (117) 117
skin cancer (116) 116
immune-response modifier (114) 114
medicine, general & internal (110) 110
lidocaine patch 5-percent (108) 108
anesthetics, local - administration & dosage (103) 103
adolescent (102) 102
antineoplastic agents - administration & dosage (100) 100
topical imiquimod (100) 100
pain (99) 99
lidocaine - administration & dosage (97) 97
analysis (92) 92
health aspects (92) 92
lidocaine (92) 92
neuropathic pain (92) 92
child (90) 90
double-blind method (90) 90
prospective studies (89) 89
follow-up studies (86) 86
adjuvants, immunologic - therapeutic use (85) 85
anesthetics, local - adverse effects (84) 84
risk factors (84) 84
carcinoma, basal cell - drug therapy (83) 83
nonmelanoma skin-cancer (83) 83
time factors (82) 82
oncology (81) 81
drug therapy (80) 80
immunology (80) 80
postherpetic neuralgia (80) 80
skin neoplasms - therapy (80) 80
basal cell carcinoma (78) 78
medicine & public health (76) 76
safety (76) 76
5-percent imiquimod cream (75) 75
diagnosis (75) 75
cream (74) 74
research (74) 74
melanoma (73) 73
randomized controlled trials as topic (73) 73
lidocaine - adverse effects (71) 71
photochemotherapy (70) 70
randomized controlled-trial (70) 70
clinical neurology (68) 68
5-percent lidocaine (67) 67
bowens-disease (67) 67
mohs micrographic surgery (66) 66
trial (65) 65
actinic keratoses (63) 63
carcinoma, basal cell - pathology (62) 62
cryotherapy (62) 62
aminoquinolines - adverse effects (61) 61
retrospective studies (61) 61
squamous cell carcinoma (60) 60
adjuvants, immunologic - administration & dosage (59) 59
aminoquinolines - pharmacology (59) 59
keratosis, actinic - drug therapy (59) 59
follow-up (57) 57
young adult (57) 57
immunotherapy (55) 55
anesthesia, spinal - adverse effects (54) 54
clinical trials (54) 54
open-label (54) 54
placebo-controlled trial (54) 54
5-percent albumin (53) 53
usage (53) 53
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1603) 1603
German (50) 50
French (27) 27
Japanese (4) 4
Turkish (4) 4
Italian (3) 3
Polish (2) 2
Portuguese (2) 2
Spanish (2) 2
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Dermatologic Surgery, ISSN 1076-0512, 08/2006, Volume 32, Issue 8, pp. 1045 - 1049
BACKGROUND Actinic keratosis (AK) is a common lesion with its highest incidence in the aged population. Although treatment strategies for AK have continued to... 
SURGERY | FLUOROURACIL | 5-PERCENT | DERMATOLOGY
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 06/2017, Volume 137, Issue 6, pp. 1367 - 1370
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 09/2019, Volume 181, Issue 3, pp. 441 - 442
Linked Article: Noels et al. Br J Dermatol 2019; 181:544–553. 
CREAM | FLUOROURACIL | 5-PERCENT | DERMATOLOGY | Medical care | Utilization
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 11/2017, Volume 31, Issue 11, pp. e505 - e507
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 02/2019, Volume 33, Issue 2, pp. e88 - e89
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 2014, Volume 28, Issue 9, pp. 1141 - 1149
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 03/2018, Volume 138, Issue 3, pp. 527 - 533
For the treatment of superficial basal cell carcinoma, a prospective, noninferiority, randomized controlled multicenter trial with 601 patients showed that 5%... 
NON-INFERIORITY | SURGERY | SINGLE-BLIND | NONINFERIORITY | DISCRETE-CHOICE EXPERIMENT | FOLLOW-UP | FLUOROURACIL | SINS | 5-PERCENT CREAM | SKIN-CANCER | DERMATOLOGY
Journal Article
BRITISH JOURNAL OF DERMATOLOGY, ISSN 0007-0963, 03/2016, Volume 174, Issue 3, pp. 505 - 513
Background Ingenol mebutate (IngMeb) is a novel patient-applied topical field therapy for actinic keratosis. Objectives To demonstrate the efficacy and safety... 
TRIAL | MANAGEMENT | THERAPY | HUMAN SKIN | CREAM | SQUAMOUS-CELL CARCINOMA | CHEMOPREVENTION | 5-PERCENT | CRYOSURGERY | PROGRESSION | DERMATOLOGY
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 11/2014, Volume 15, Issue 12, pp. 1361 - 1368
Background Vulval intraepithelial neoplasia is a skin disorder affecting the vulva that, if left untreated, can become cancerous. Currently, the standard... 
WOMEN | ONCOLOGY | IRNIQUIMOD | TOPICAL IMIQUIMOD | QUALITY-OF-LIFE | EXCISION | NATURAL-HISTORY | CARCINOMA | 5-PERCENT CREAM | IN-SITU
Journal Article
Journal Article
JAMA Dermatology, ISSN 2168-6068, 08/2018, Volume 154, Issue 8, pp. 879 - 881
Journal Article
Molecular Medicine, ISSN 1076-1551, 01/2011, Volume 17, Issue 1-2, pp. 113 - 125
Journal Article
Journal of drugs in dermatology : JDD, ISSN 1545-9616, 03/2018, Volume 17, Issue 3, pp. 347 - 354
Dermatophytoma is a little-known, difficult to treat fungal infection that complicates onychomycosis. First described by Roberts and Evans in the late 1990's,... 
AGENT | TOENAIL ONYCHOMYCOSIS | EFFICACY | DRUG-DELIVERY | SAFETY | 5-PERCENT | DERMATOLOGY
Journal Article
The Journal of Immunology, ISSN 0022-1767, 05/2009, Volume 182, Issue 9, pp. 5836 - 5845
Journal Article